Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
afuresertib (LAE002)
i
Other names:
GSK 2110183C, GSK-2110183, GSK-2110183C, LAE002, ASB183, 2110183, GSK2110183, GSK2110183C, ASB-183, LAE 002, LAE-002, ASB 183, GSK 2110183
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Laekna Therap, Qilu Pharma
Drug class:
pan-AKT inhibitor
Related drugs:
‹
ARQ 751 (5)
MK-7075 (0)
ARQ 751 (5)
MK-7075 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
HR positive
HER2 Negative Breast Cancer
HR positive
HER2 Negative Breast Cancer
LAE002
Sensitive: C3 – Early Trials
LAE002
Sensitive
:
C3
LAE002
Sensitive: C3 – Early Trials
LAE002
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.